More than 16,000 people attended the 76th Scientific Sessions of the American Diabetes Association (ADA) in New Orleans, LA, last week. It’s the largest global gathering of experts in diabetes research and clinical care, and JDRF scientific staff and grantees were right in the heart of it. JDRF Vice President of Discovery Research Julia Greenstein, Ph.D., explained why it was exciting for JDRF’s scientific staff to be there.
Artificial pancreas systems stole the show with hotly anticipated results from multiple JDRF-supported clinical trials. Hear about JDRF’s role and impact in this space from JDRF’s industry partners, grantees and supporters.
The psychosocial impact of managing T1D was also big news, with young people front and center. Find out what JDRF-funded researchers have learned about the links between psychosocial factors and T1D outcomes in teens and what teens themselves say about managing T1D.
JDRF grantees including Jonathan Lakey, Ph.D. (University of California, Irvine), put the focus on encapsulation technologies in a session about protecting the beta cell. Learn why participating in the conference is so valuable to researchers like Dr. Lakey.
Why It Matters
The ADA Scientific Sessions provide a platform for JDRF to celebrate our recent progress and plot our next steps in creating a world without type 1 diabetes.
Support JDRF today and fuel the research that will be making headlines next!